Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

Dr Josef Köhrle, discusses with Lorna Rothery the urgent need for stronger actions to address the potential health risks ...

Researchers revealed that the microbial metabolite TMA can directly block the immune protein IRAK4, reducing inflammation and ...

Understanding how the cells that control blood sugar work is crucial to preventing and treating diabetes. Researchers at Karolinska Institutet have now developed a technique that makes it possible to ...

The U.S. Food and Drug Administration approved Arrowhead Pharmaceuticals' drug for a type of genetic disorder that causes ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

A new paper from the University of Kansas overturns the idea that a "risk gene" carried by millions of people worldwide ...

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...